Merck - 48 Year Stock Price History | MRK

Historical daily stock prices for Merck since 1970 adjusted for splits and dividends. Open, high, low, close (OHLC) data as well as percentage changes for multiple date ranges. Display 20, 50 and 200 day moving averages and export charts as images to use in articles and blogs. The latest closing price for Merck (MRK) as of July 17, 2018 is 62.53.
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $92.237B $40.122B
Merck & Co., Inc., a leading global biopharmaceutical company known as MSD outside of the United States and Canada, has been inventing for life, bringing forward medicines and vaccines for many of the world's most challenging diseases. Through their prescription medicines, vaccines, biologic therapies and animal health products, they work with customers and operate the countries to deliver innovative health solutions. The Company also demonstrate their commitment to increasing access to health care through far-reaching policies, programs and partnerships. Merck continues to be at the forefront of research to advance the prevention and treatment of diseases that threaten people and communities around the world - including cancer, cardio-metabolic diseases, emerging animal diseases, Alzheimer's disease and infectious diseases including HIV and Ebola.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $334.531B 16.56
Pfizer (PFE) United States $222.518B 13.69
Novartis AG (NVS) Switzerland $182.129B 15.78
AbbVie (ABBV) United States $152.737B 15.57
Novo Nordisk (NVO) Denmark $121.004B 20.05
Sanofi (SNY) France $104.713B 13.25
GlaxoSmithKline (GSK) United Kingdom $102.153B 13.97
Eli Lilly (LLY) United States $96.679B 19.20
AstraZeneca (AZN) United Kingdom $92.856B 9.72
Bristol-Myers Squibb (BMY) United States $92.237B 18.15